Region:Middle East
Author(s):Shubham
Product Code:KRAD0873
Pages:89
Published On:November 2025
By Type:The hemostats market can be segmented into various types, including absorbable hemostats, non-absorbable hemostats, oxidized regenerated cellulose-based hemostats, thrombin-based hemostats, and combination hemostats. Among these, absorbable hemostats, particularly gelatin-based and collagen-based products, are gaining significant traction due to their effectiveness, superior biocompatibility, and ease of use in surgical procedures. The adoption of advanced absorbable hemostats is further supported by the increasing preference for minimally invasive surgeries and the need for rapid hemostasis in complex procedures .
By End-User:The hemostats market is segmented by end-user into hospitals & clinics, ambulatory surgical centers, trauma & emergency care centers, and specialty surgical facilities. Hospitals & clinics dominate this segment due to the high volume of surgical procedures performed in these settings, necessitating the use of effective hemostatic products. Ambulatory surgical centers are experiencing rapid growth, driven by the increasing shift toward outpatient procedures and the adoption of minimally invasive techniques .
The UAE Hemostats Market is characterized by a dynamic mix of regional and international players. Leading participants such as Johnson & Johnson (SURGICEL, EVICEL, SURGIFLO), Medtronic plc, Baxter International Inc., B. Braun Melsungen AG, Integra LifeSciences Corporation (SurgiMend, DuraGen), Becton Dickinson and Company (C.R. Bard), CryoLife, Inc. (Artivion - PerClot, BioGlue), Stryker Corporation, Terumo Corporation, Medline Industries, Inc., Z-Medica LLC (QuikClot), Cohera Medical, Inc., 3M Company (Acelity), Vascular Solutions, Inc., Hemostasis, Inc. contribute to innovation, geographic expansion, and service delivery in this space.
The future of the UAE hemostats market appears promising, driven by ongoing advancements in medical technology and an increasing focus on patient-centered care. As healthcare providers prioritize minimally invasive procedures, the demand for innovative hemostatic solutions is expected to rise. Additionally, the expansion of healthcare infrastructure and increased government funding for medical research will likely foster further growth, enabling the introduction of more effective and affordable hemostatic products in the market.
| Segment | Sub-Segments |
|---|---|
| By Type | Absorbable Hemostats (Gelatin-based, Collagen-based) Non-Absorbable Hemostats (Fibrin Sealants, Synthetic Sealants, Hemostatic Gauze) Oxidized Regenerated Cellulose-based Hemostats Thrombin-based Hemostats Combination Hemostats |
| By End-User | Hospitals & Clinics Ambulatory Surgical Centers Trauma & Emergency Care Centers Specialty Surgical Facilities |
| By Application | General Surgery Orthopedic Surgery Cardiovascular Surgery Neurological Surgery Gynecological Surgery Dental Treatments Trauma Management |
| By Distribution Channel | Direct Sales to Healthcare Facilities Medical Device Distributors Hospital Group Procurement Online Medical Supply Platforms |
| By Geography | Abu Dhabi Dubai Sharjah Ajman Ras Al Khaimah Other Emirates |
| By Product Formulation | Matrix & Gel Hemostats Sheets & Pads Sponge Hemostats Powder Hemostats Liquid Hemostats (Fibrin Sealants) |
| By Regulatory Approval Status | CE Marked Products FDA Approved Products UAE Ministry of Health Approved Products Products Under Review |
| Scope Item/Segment | Sample Size | Target Respondent Profiles |
|---|---|---|
| General Surgery Hemostats | 100 | Surgeons, Surgical Nurses |
| Trauma Surgery Applications | 80 | Emergency Room Physicians, Trauma Surgeons |
| Orthopedic Surgery Products | 70 | Orthopedic Surgeons, Surgical Assistants |
| Cardiovascular Surgery Hemostats | 60 | Cardiothoracic Surgeons, Anesthesiologists |
| Dental Hemostatic Agents | 50 | Dentists, Oral Surgeons |
The UAE Hemostats Market is valued at approximately USD 30 million, reflecting a five-year historical analysis. This growth is attributed to the increasing number of surgical procedures and advancements in minimally invasive surgical techniques.
What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.
